Clinical trial
A Phase I/II Trial of Sirolimus (Rapamune) and Cyclosporine in Patients With Refractory Aplastic Anemia
NCT00319878 is registered in ClinicalTrials.gov with Office of Rare Diseases (ORD) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/II Trial of Sirolimus (Rapamune) and Cyclosporine in Patients With Refractory Aplastic Anemia
- Lead sponsor
- Office of Rare Diseases (ORD)
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- May 31, 2006
- Completion date
- December 31, 2009
- Enrollment
- 52 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.